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INTRODUCTION
Group A human rotavirus is a major etiologic agent of severe
diarrhea in infants and young children in both developing and
developed countries. Furthermore, it is the cause of death in
approximately 600,000 children annually in developing coun-
tries (1, 2). Large scale studies in Korea have also shown that
rotavirus was responsible for 24% to 46% of the hospitalized
children with acute gastroenteritis (3, 4). Because of the large
disease burden caused by rotavirus, prevention of rotavirus
diarrhea is a major global health priority (1, 5). To design a
vaccine strategy and to evaluate the success of candidate vac-
cines, it is essential to know the serotypes or genotypes of
prevailing rotavirus strains in each country or region (6).
Group A rotaviruses possess a genome consisting of 11 seg-
ments of double-stranded RNA enclosed in a triple-layered
capsid. The outer layer is composed of two proteins, VP4 and
VP7, that elicit neutralizing antibody responses and that form
the basis of the current dual classification system in G (VP7)
and P (VP4) serotypes or genotypes. G serotypes have been
identified by neutralization or enzyme-linked immunosor-
bent assay (ELISA), but genotyping of the G gene by nucleic
acid amplification technique has been developed to facilitate
rotavirus strain characterization (7). However serologic clas-
sification of P type has been more difficult because hyperim-
mune sera that distinguish individual P serotypes are not rea-
dily available. Instead, the nucleic acid amplification technique
has been a reliable surrogate for the serotyping of P types (8).
Most of the studies conducted in Korea used ELISA to deter-
mine G serotypes and more than 90% of rotavirus isolates
belonged to one of the four common G serotypes (G1-4) (3).
More recently, both G and P genotyping studies have been
reported in Korea (9-11). While conducting the rotavirus
genotyping study in our institution, there have been many
reports on outbreaks of rotavirus diarrhea in hospitals or in
postpartum care facilities in Korea (12-14). But reports on
association of rotavirus genotypes and nosocomial infections
have been limited, so we tried to find any association of rota-
virus genotypes and nosocomial infections.
MATERIALS AND METHODS
Specimens
Stool specimens from hospitalized pediatric patients with
diarrhea were tested for rotavirus antigen by enzyme immu-
noassay (Vidas Rotavirus, bioMerieux sa, France). A total of
103 rotavirus-positive specimens (53 positive specimens in
July 2001-June 2002 and 50 positives in July 2002-June
2003) were collected in Hanyang University Guri Hospital,
in Gyeonggi province, Korea.
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G and P Genotyping of Human Rotavirus Isolated in a University
Hospital in Korea: Implications for Nosocomial Infections
To characterize rotavirus G and P genotypes circulating among infants and young
children hospitalized with severe diarrhea in a university hospital in Gyeonggi pro-
vince, Korea, and to examine any association of the genotypes and nosocomial
infections, we genotyped 103 isolates of rotavirus by multiplex RT-PCR. In July 2001-
June 2002, we found that globally common strains constituted 64.2% (G2P[4] 28.3%,
G3P[8] 28.3%, G4P[8] 5.7%, and G1P[8] 1.9%), and the uncommon strain, G4P[6],
constituted 26.4%. During July 2002-June 2003, the percentage of common strains
decreased to 44.0% (G3P[8] 18.0%, G2P[4] 16.8%, and G1P[8] 10.0%), but G4P[6]
increased to 36.0%. G9P[8] was identified in 10.0% of cases, and thus can be con-
sidered an emerging strain in Korea. Eight-eight percent of G4P[6] was isolated from
newborn babies. Among the 103 patients, there was an evidence of nosocomial
rotavirus infection in 23 children (22.3%). Of these, 19 (82.6%) were newborns in-
fected with G4P[6] strains of rotavirus. Most of the children who acquired rotavirus
infection nosocomially showed symptoms of diarrhea, vomiting, fever, poor sucking,
or dehydration, regardless of the genotype. This study revealed that G4P[6] has
been the major genotype causing nosocomial rotavirus infection in our hospital.
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Rotavirus RNA extraction
RNA was extracted with a commercially available mixture
of phenol and guanidine thiocyanate (Tri Reagent LS, Molec-
ular Research Center Inc., Cincinnati, OH, U.S.A.). Isolation
of total RNA was performed according to the manufacture’s
instructions. Briefly, Tri Reagent LS was mixed with a 20%
stool suspension in phosphate buffered saline (PBS) at a pH
of 7.2 at a volume ratio of 3 to 1. After complete dissociation
of nucleoprotein complexes, chloroform was added to the
mixture followed by vigorous shaking and centrifugation at
12,000 g for 15 min at 4℃. The upper aqueous phase was
transferred to a fresh tube and the RNA precipitated by mix-
ing with isopropanol. The supernatant was removed and the
RNA pellet was washed once with 75% ethanol. The RNA
pellet was then briefly air-dried and dissolved in diethyl pyro-
carbonate (DEPC) treated water.
Reverse transcription-polymerase chain reaction
RT-PCR methods for VP7 and VP4 genes are based on pre-
viously determined conditions used by Gentsch et al. (8) and
Das et al. (15). Briefly, 1.2  L of each of the primers, 9con1
and 9con2 for the VP7 gene (15), con3 and con2 for VP4 gene
(8), and 5  L RNA extract was added to the RT PreMix (Bio-
neer Inc., Daejeon, Korea), consisting of 4  L 5× RT buffer
(250 mM Tris-HCl, 150 mM KCl, 40 mM MgCl2, pH 8.3),
2  L 100 mM dithiothreitol, 0.5  L deoxynucleoside tripho-
sphate (dNTP) mix (dATP, dCTP, dGTP, and dTTP; each
10 mM), 20 units RNase inhibitor, and 200 units M-MLV
RTase (Bioneer Inc.). The reaction mixture was then incu-
bated at 42℃ for one hour. PCR PreMix (Bioneer Inc.) con-
sisting of 1 unit Taq DNA polymerase, deoxynucleoside tri-
phosphate (dNTP) mix (dATP, dCTP, dGTP, and dTTP; each
250 mM), 10 mM Tris-HCl (pH 9.0), 40 mM KCl, and 1.5
mM of MgCl2 was added to each tube, and then loaded into
a preheated (94℃) Perkin Elmer thermal cycler (Gene Amp
PCR System 9600, PerkinElmer Inc., Wellesley, MA, U.S.A.).
PCR was performed as follows: 1 cycle at 94℃ for 5 min;
30 cycles at 94℃ for 0.5 min, 42℃ for 0.5 min, and 72℃
for 1 min; and 1 cycle at 72℃for 7 min. 
Nested multiplex PCR for G and P genotyping
For G (VP7) genotyping, 1.2  L of 10  M 9con1 primer
and each type-specific primer (9T-1, 9T-2, 9T-3P, 9T-4, 9T-
9B) were used (15). For VP4 genotyping, 1.2  L of 10  M
con3 primer and each type-specific primer (1-T1, 2-T1, 3-
T1, 4-T1, 5T-1, ND2) were used (8). Conditions for the Nest-
ed PCR were identical to those used for the PCR described
above. Five to ten  L of PCR products are analyzed on a 1.5%
TBE agarose gel (Sigma-Aldrich, St. Louis, MO, U.S.A.) and
viewed under ultraviolet illumination after ethidium bromide
staining.
Medical record review
Individual patient records for children in whom rotavirus
strains were genotyped were retrospectively reviewed to deter-
mine the presence of diarrhea (defined as three or more looser
than normal stool passages within one day), fever (>38℃),
nausea, vomiting, abdominal pain, and other symptoms such
as poor oral intake.
Definition of nosocomial infection
Nosocomial rotavirus infection was defined as the presence
of acute signs and symptoms of gastroenteritis (diarrhea, vom-
iting, fever, nausea, abdominal pain, or poor feeding), begin-
ning 3 or more days following admission to the hospital for
a non-diarrheal illness, and the presence of a rotavirus antigen
in stool specimen (16).
RESULTS
From July 2001 to June 2003, a total of 1,031 fecal spec-
imens were tested for rotavirus antigen at our hospital. Dur-
ing the two epidemic seasons of 2001-2002 and 2002-2003,
Bold letters represent epidemic months (positive % greater than average
positive rate).
Year Month
No. 
specimen
No. 
positive
% 
positive
2001 Jul 21 0 0.0
Aug 41 5 12.2
Sep 24 3 12.5
Oct 47 6 12.8
Nov 56 5 8.9
Dec 33 13 39.4
2002 Jan 40 20 50.0
Feb 30 12 40.0
Mar 44 14 31.8
Apr 70 26 37.1
May 66 21 31.8
Jun 48 13 27.1
Jul 71 21 29.6
Aug 36 9 25.0
Sep 40 10 25.0
Oct 51 10 19.6
Nov 57 9 15.8
Dec 32 3 9.4
2003 Jan 42 9 21.4
Feb 34 12 35.3
Mar 40 20 50.0
Apr 41 21 51.2
May 27 9 33.3
Jun 40 6 15.0
Total 1,031 277 26.9
Table 1. Monthly percentages of rotavirus-positive specimens
and peak months in Hanyang University Guri Hospital, July 2001
through June 2003Genotyping of Rotavirus and Nosocomial Infection 985
26.5% and 27.2% of stool specimens were positive for rota-
virus. During the summer months of 2002 (June through
August), the proportion of rotavirus-positive stool specimens
was unusually high (27.7%). The 2002-2003 epidemic began
on January 2003 and peaked from February through May
2003 (Table 1).
Among the 277 rotavirus antigen-positive specimens, we
could genotype 103 strains (37.2%), and the rest of the spec-
imens were too small in quantity to be genotyped. In the first
year, globally common strains constituted 64.2%, while the
uncommon strain, G4P[6] constituted 26.4%. During the
second year, the proportion of common rotavirus strains de-
clined to 44.0%. In 2002-2003, G4P[6] increased to 36.0%
and globally emerging G9P[8] strain (10.0%) was detected
(Table 2). One case of G4P[6] was identified in August 2001
and 11 additional cases were clustered during November 2001
through January 2002. In the 2002-2003 season, G4P[6]
strains (n=18) were detected throughout the year. Analysis
*Globally uncommon strains, 
� Not typeable.
Genotype
No. (%) of isolates
July 2001-
June 2002
July 2002-
June 2003
Total
No. (%)
Common strains*
G1 P8 1 5 6
G2 P4 15 8 23
G3 P8 15 9 24
G4 P8 3 0 3
Subtotal 34 (64.2) 22 (44.0) 56 (54.4)
Uncommon strains*
G2 P9 0 1 1
G3 P9  1 0 1
G3 P(4+8) 0 2 2
G4 P6 14 (26.4) 18 (36.0) 32 (31.1)
G9 P8 0 5 5
G(1+3) P 8 2 0 2
G(2+3) P(4+9) 1 0 1
G NT
�P8 1 2 3
Subtotal 19 (35.8) 28 (56.0) 47 (45.6)
Total 53 50 103
Table 2. The difference of rotavirus P and G genotypes each
year, identified in Hanyang University Guri Hospital
Specimen No.  Date of collection Age Sex Genotype Symptom or sign Others
1 0108-57 01-08-10 10 d M G4P[6] Poor sucking
2 0111-2 01-11-01 27 d M G4P[6] LS C/S
3 0111-60 01-11-12 25 d M G4P[6] LS, V C/S
4 0111-143 01-11-27 5 d F G4P[6] D transfer
5 0112-126 01-12-26 2 m M G2P[4] D, F, V, DH
6 0112-128 01-12-26 21 d M G4P[6] D, F, V
7 0201-38 02-01-09 6 d F G4P[6] D C/S
8 0201-39 02-01-09 6 d F G4P[6] D C/S
9 0201-72 02-01-14 8 d M G4P[6] V
10 0202-10 02-02-04 42 m M G3P[8] D, F, V
11 0206-167 02-06-25 6 d F G4P[6] D C/S
12 0209-131 02-09-19 13 m M G3P[8] D, F, V
13 0209-143 02-09-23 7 d F G4P[6] D C/S
14 0209-167 02-09-25 14 d F G4P[6] V C/S
15 0211-156 02-11-20 7 d M G4P[6] D, Poor sucking C/S
16 0212-53 02-12-05 10 d M G4P[6] D C/S
17 0212-96 02-12-11 9 d M G4P[6] D C/S
18 0302-119 03-02-18 13 d M G4P[6] D C/S
19 0302-6 03-02-03 24 m F G1P[8] D, F, V
20 0302-32 03-02-06 9 d M G4P[6] D
21 0305-28 03-05-06 8 d M G4P[6] V C/S
22 0305-111 03-05-19 16 d M G4P[6] D
23 0305-133 03-05-21 7 d F G4P[6] D
Table 3. Genotypes, symptoms, or signs of nosocomially acquired rotavirus infection
D, diarrhea; DH, dehydration; F, fever; LS, loose stool; V, vomiting; C/S, Cesarean section; d, days; m, months. 
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Fig. 1. Age distribution of commonly isolated rotavirus genotypes
in Hanyang University Guri Hospital from July 2001 through June
2003.
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of the clinical pediatric data revealed that seven of 32 patients
(21.8%) shed the G4P[6] rotavirus strain but did not have
diarrhea. These seven children experienced relatively mild
disease with loose stool, fever, or poor feeding. Eighty-eight
percent (28/32) of G4P[6] strains were isolated from new-
borns. In contrast, 83.0% of the globally common strains
(G2P[4] and G3P[8]) were isolated from children aged 6-
35 months (Fig. 1).
Among the 103 patients whose charts were reviewed for
the evidence of nosocomial infection, 23 (22.3%) were con-
firmed to have nosocomially-acquired rotavirus infection. Of
the 23 children with confirmed nosocomial rotavirus infec-
tion, 19 (82.6%) were infected with G4P[6] strain and all
were neonates (<30 days old). Other nosocomially acquired
genotypes including one strain of G1P[8], one G2P[4], and
two G3P[8] were found among children aged 2-42 months.
Most infants who acquired rotavirus infection nosocomially
showed symptoms of diarrhea, vomiting, fever, poor sucking,
or dehydration regardless of genotype. Twelve children (52.2
%) were born by Cesarean section (Table 3).
DISCUSSION
Our two year study showed that the positive rate of rotavirus
antigen among hospitalized children with gastroenteritis was
27% and this result is consistent with our previous ten year
report (17) and a nationwide three year study in Korea (4).
During this study period, the epidemic of rotavirus, which
had begun in December 2001, continued through July 2002.
This prolonged rotavirus epidemic that extended into the
summer months (positive rate of 28%) was very unusual.
Moreover, in 2003, a rotavirus peak appeared in the spring
months (46% vs. 22% of winter season). Our previous study
showed that the annual epidemic peaks of rotavirus diarrhea
occurred in October, November, and December from 1989
through 1992. However, the peak time of rotavirus infection
has gradually moved from December-January to February-
March since 1993-94 (17). The underlying reasons for the
change in the peak rotavirus season could not be explained
by experimental evidence nor by errors in laboratory testing,
but global warming could possibly influence the temperature
in Korea and thus the rotavirus epidemic. Similar shifting
of peak rotavirus activity from winter to spring has also been
reported in Japan (18).
A recent report of global rotavirus strain collections reveal-
ed that four common G types (G1, G2, G3, and G4) in con-
junction with P[8] or P[4] types represented over 88% of
the rotavirus strains, but unusual or uncommon G and P types
have been reported from various parts of the world (19). Re-
cently, the G9 strain has been identified in a growing num-
ber of countries (20-24), and the neonatal type P[6] combined
with G1, G3, G4, or G9 specificity, is emerging (25-28). The
circulating strains of rotavirus differ by country and geogra-
phic region. In developed countries, the G1P[8] strain rep-
resents over 70% of rotavirus serotypes/genotypes, but only
about 30% in South America and Asia, and 23% in Africa
(19). P[6] represents almost one-third of all P types identi-
fied in Africa and 27% of the rotavirus infections were asso-
ciated with strains bearing unusual combinations such as
G8P[6] or G8P[4]. Previous serotyping studies of rotavirus
conducted in Korea demonstrated that from 1987 until 1997,
G1 was most prevalent strain and serotype G1-4 constituted
more than 95% of serotyped strains (3). During the 1998-
1999 epidemics, the G4 serotype became the most prevalent
serotype, accounting for 58% of the serotyped strains. Recent
reports from Korea revealed that G1, G2, G3, and G4 types
constituted 96% (9), 87% (10), and 84% (11) of rotavirus
strains.
In our study, the percentages of common G and P combin-
ed genotypes were different by year. The globally common
G and P genotypes constituted 64.2% of infections in the
2001-2002 season, but decreased to 44.0% in the 2002-2003
season. The incidence of G2P[4] in the 2001-2002 season
was quite high (28.3%) compared to the major global reports
of 12% (19). The high incidence of uncommon genotypes
was due mostly to the epidemic of G4P[6] strains (26.4%
in 2001-2002 and 36.0% in 2002-2003), but in part due
to the new emergence of G9P[8] strains since February 2003.
The G9P[8] genotype, which has been a globally emergent
strain, constituted 10% of specimens genotyped during 2002-
2003. Overall, 54.4% of the strains genotyped for the two
year period belonged to the globally common genotypes
(Table 2). 
The most intriguing result of our recent two year rotavirus
genotyping study was the high incidence of the globally un-
common genotype, G4P[6](31.1%), which is far higher than
the results of Min et al. from Korea (10), and is actually the
highest percentage of G4P[6] yet reported worldwide (19,
25). Although P[6] combined with G4 is considered rare
globally and is reported to be associated with asymptomatic
or symptomatic infections, P[6] strains combined with G1,
G2, G3, or G4 have recently increased as a result of nosoco-
mial rotavirus outbreaks in hospitals and newborn nurseries
(25-29). There have been reports of rotavirus diarrhea epide-
mics in hospital nurseries and in postpartum care facilities
in Korea since 2001 (12-14), and several hospitals even closed
their newborn nurseries for a few months because it was so
difficult to control the rotavirus transmission. From a hospi-
tal where a large epidemic of diarrhea in a newborn nursery
occurred, we received 27 rotavirus antigen positive specimens
(by latex agglutination) and genotyped them by RT-PCR.
Except for one PCR-negative specimen, the remaining 26
were typed as G4P[6] (unpublished data). During the epi-
demic of G4P[6] rotavirus in newborn nurseries in Korea,
many of the newborns suffered from severe diarrhea or even
death in selected cases (14). 
Our study revealed that among the 103 patients who shedGenotyping of Rotavirus and Nosocomial Infection 987
rotavirus in their stool, there was evidence of nosocomial infec-
tion in 23 children (22.3%). Among the 23 nosocomially-
infected children, 19 (82.6%) were infected with G4P[6]
strains, all of whom were newborn babies. A hospital-based
study over ten years in Germany reported nosocomial infec-
tion rate of rotavirus as being as high as 50% (29). Most stud-
ies to date have indicated that the neonatal rotavirus infec-
tion is predominantly asymptomatic, although severe diar-
rhea has been described in some instances (25). It remains
unknown whether the attenuated infection in neonates is due
to host factors or virulence factors of the neonatal rotavirus
strains. In our study, most of the newborns positive for G4P[6]
strains of rotavirus had symptoms (Table 3). This could be
explained, in part, due to the selective testing of rotavirus
for the symptomatic patients.
Although 92% of rotavirus strains isolated in our study
belonged to the common G types, the newly emerging G9P[8]
strains first appeared in Korea during February 2003. There-
fore, a continued and nationwide genotype surveillance of
rotavirus is needed to monitor changes in strain prevalence,
to identify the emergence of new strains over time that could
affect future vaccine strategies, and to identify any regional
differences of genotype prevalence within Korea. 
In summary, this study has extended our knowledge of
rotavirus genotype diversity and highlights several impor-
tant factors of rotavirus epidemiology in Korea. First, our
study demonstrates that a globally rare strain, G4P[6], was
the major epidemic strain in a university hospital in Korea.
Secondly, the G4P[6] strain was the major cause of nosoco-
mial rotavirus infection and was isolated mostly in newborn
babies. Lastly, during the study period, the globally emerg-
ing strain G9P[8] was detected as a strain now emerging in
Korea. 
REFERENCES
1. Wuethrich B, ed. Proceedings of the sixth international rotavirus
symposium. 1st ed. Washington DC: The Albert B. Sabin Institute,
2005.
2. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI.
Global illness and deaths caused by rotavirus disease in children.
Emerg Infect Dis 2003; 9: 565-72.
3. Seo JK, Sim JG. Overview of rotavirus infections in Korea. Pediatr Int
2000; 42: 406-10.
4. Kang JO, Kim MN, Kim J, Suh HS, Yoon Y, Jang S, Chang C, Choi
S, Nyambat B, Kilgore PE. Epidemiologic trends of rotavirus infection
in Republic of Korea, July 1999 through June 2002. Korean J Lab
Med 2003; 23: 382-7.
5. Glass RI, Bresee JS, Parashar UD, Jiang B, Gentsch J. The future of
rotavirus vaccines: a major setback leads to new opportunities. Lancet
2004; 363: 1547-50. 
6. Hoshino Y, Kapikian AZ. Rotavirus serotypes: Classification and
importance in epidemiology, immunity, and vaccine development. J
Health Popul Nutr 2000; 18: 5-14.
7. Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B,
Fang ZY. Polymerase chain reaction amplification and typing of
rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990;
28: 276-82.
8. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J,
Das BK, Bhan MK. Identification of group A rotavirus gene 4 types
by polymerase chain reaction. J Clin Microbiol 1992; 30: 1365-73.
9. Song MO, Kim KJ, Chung SI, Lim I, Kang SY, An CN, Kim W. Dis-
tribution of human group A rotavirus VP7 and VP4 types circulat-
ing in Seoul, Korea between 1998 and 2000. J Med Virol 2003; 70:
324-8.
10. Min BS, Noh YJ, Shin JH, Baek SY, Kim JO, Min KI, Ryu SR, Kim
BG, Kim DK, Lee SH, Min HK, Ahn BY, Park SN. Surveillance study
(2000 to 2001) of G- and P-type human rotaviruses circulating in
South Korea. J Clin Microbiol 2004; 42: 4297-9. 
11. Kang JO, Kilgore P, Kim JS, Nyambat B, Kim J, Suh HS, Yoon Y,
Jang S, Chang C, Choi S, Kim MN, Gentsch J, Bresee J, Glass R.
Molecular epidemiological profile of rotavirus in South Korea, July
2002 through June 2003: Emergence of G4P[6] and G9P[8] strains.
J Infect Dis 2005; 192 (Suppl 1): 57-63.
12. Jang JM, Kim MJ, Cheong HW, Park DW, Sohn JW, Son CS, Lee
SE. The epidemiologic characteristics and infection control measures
for an outbreak of rotavirus infection in the neonatal unit. Infect Che-
mother 2005; 37: 311-8.
13. Korea CDC. Rotavirus detection in newborn babies in a day-care cen-
ter in Goyang city, Gyeonggi province. CDMR 2003; 14: 284.
14. Yang KM, Park SH, Kim IS, Lee JH, Lee HY, Kwon TJ, Lee WT,
Kang SM, Yang BK, Goh UY, Ji YM. Report of newborn deaths at
post-delivery care facilities in 2001 and 2002. Korean J Leg Med
2002; 26: 33-46.
15. Das BK, Gentsch JR, Cicirello HG, Woods PA, Gupta A, Ramachan-
dran M, Kumar R, Bhan MK, Glass RI. Characterization of rotavirus
strains from newborns in New Delhi, India. J Clin Microbiol 1994;
32: 1820-2.
16. Farr BM. Nosocomial gastrointestinal tract infections. In: Mayhall
CG. editor, Hospital Epidemiology and Infection Control. 2nd ed.
Philadelphia, USA: Lippincott Willams & Wilkins, 1999; 247-74.
17. Kang JO, Kim SE, Kim TY, Park IK, Choi TY. Trends in rotavirus
gastroenteritis in Korea from 1989 through 1998 and comparison
of Slidex Rota-kit 2 and VIDAS Rotavirus. Korean J Clin Microbiol
1999; 2: 152-5.
18. Suzuki H, Sakai T, Tanabe N, Okabe N. Peak rotavirus activity shift-
ed from winter to early spring in Japan. Pediatr Infect Dis J 2005;
24: 257-60. 
19. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/geno-
types and its implication for the development and implementation of
an effective rotavirus vaccine. Rev Med Virol 2005; 15: 29-56.
20. Unicomb LE, Podder G, Gentsch JR, Woods PA, Hasan KZ, Faruque
AS, Albert MJ, Glass RI. Evidence of high-frequency genomic rea-
ssortment of group A rotavirus strains in Bangladesh: Emergence
of type G9 in 1995. J Clin Microbiol 1999; 37: 1885-91.
21. Steele AD, Ivanoff B. Rotavirus strains circulating in Africa during
1996-1999: emergence of G9 strains and P[6] strains. Vaccine 2003;988 J.O. Kang, C.R. Kim, P.E. Kilgore, et al.
21: 361-7.
22. Clark HF, Lawley DA, Schaffer A, Patacsil JM, Marcello AE, Glass
RI, Jain V, Gentsch J. Assessment of the epidemic potential of a new
strain of rotavirus associated with the novel G9 serotype which caused
an outbreak in the United States for the first time in the 1995-1996
season. J Clin Microbiol 2004; 42: 1434-8.
23. Santos N, Volotao EM, Soares CC, Albuquerque MC, da Silva FM,
de Carvalho TR, Pereira CF, Chizhikov V, Hoshino Y. Rotavirus
strain bearing genotype G9 or P[9] recovered form Brazilian chil-
dren with diarrhea from 1997 to 1999. J Clin Microbiol 2001; 39:
1157-60.
24. Griffin DD, Kirkwood CD, Parashar UD, Woods PA, Bresee JS, Glass
RI, Gentsch JR. Surveillance of rotavirus strains in the United States:
Identification of unusual strains. J Clin Microbiol 2000; 38: 2784-7.
25. Gentsch JR, Woods PA, Ramachandran M, Das BK, Leite JP, Alfieri
A, Kumar R, Bhan MK, Glass RI. Review of G and P typing results
from a global collection of rotavirus strains: implications for vaccine
development. J Infect Dis 1996; 174 (Suppl 1): 30-6.
26. Widdowson MA, van Doornum GJ, van der Poel WH, de Boer AS,
Mahdi U, Koopmans M. Emerging group-A rotavirus and a noso-
comial outbreak of diarrhoea. Lancet 2000; 356: 1161-2.
27. Lee CN, Lin CC, Kao CL, Zao CL, Shih MC, Chen HN. Genetic
characterization of the rotaviruses associated with a nursery outbreak.
J Med Virol 2001; 63: 311-20.
28. Linhares AC, Mascarenhas JD, Gusmao RH, Gabbay YB, Fialho
AM, Leite JP. Neonatal rotavirus infection in Belem, Nothern Brazil:
Nosocomial transmission of a P[6]G2 strains. J Med Virol 2002; 67:
418-26.
29. Berner R, Schumacher RF, Hameister S, Forster J. Occurrence and
impact of community-acquired and nosocomial rotavirus infections--
a hospital-based study over 10 y. Acta Paediatr Suppl 1999; 426:
48-52.